ArticleThe Journal of infectious diseases2011

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.

Paul Spearman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.